Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Fanikos

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Pharmacotherapy|July 2, 2013
Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopeniaKatelyn W Sylvester, John Fanikos, Kevin E Anger, et al.
Journal of Pharmacy Practice|June 8, 2021
Non-Sterile to Sterile Compounding: An Unconventional Response During the COVID-19 PandemicCaryn D Belisle, Kevin Anger, Dareen Kanaan, et al.
Blood Advances|September 10, 2021
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysisJohn Fanikos, Kathleen Marquis, Leo Buckley, et al.
Thrombosis and Haemostasis|August 31, 2019
Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance ProgramJohn Fanikos, Debra Murwin, Fredrik Gruenenfelder, et al.
Arthritis and Rheumatism|December 13, 2005
Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical centerSandeep K Agarwal, Agnes L Maier, Lori B Chibnik, et al.
Joint Commission Journal on Quality and Patient Safety|March 30, 2006
How many hospital pharmacy medication dispensing errors go undetected?Jennifer L Cina, Tejal K Gandhi, William Churchill, et al.
Thrombosis and Haemostasis|September 16, 2021
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO TrialBehnood Bikdeli, Heather Hogan, Ruth B Morrison, et al.
Journal of Pharmacy Practice|July 20, 2024
Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa InhibitorsToni Fera, Allison Burnett, Jessica Grandoni, et al.
Journal of the American College of Cardiology|October 30, 2020
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19Gregory Piazza, Umberto Campia, Shelley Hurwitz, et al.
Journal of the American Medical Informatics Association : JAMIA|March 23, 2016
The frequency of inappropriate nonformulary medication alert overrides in the inpatient settingQoua L Her, Mary G Amato, Diane L Seger, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Pharmacotherapy|July 2, 2013
Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopeniaKatelyn W Sylvester, John Fanikos, Kevin E Anger, et al.
Journal of Pharmacy Practice|June 8, 2021
Non-Sterile to Sterile Compounding: An Unconventional Response During the COVID-19 PandemicCaryn D Belisle, Kevin Anger, Dareen Kanaan, et al.
Blood Advances|September 10, 2021
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysisJohn Fanikos, Kathleen Marquis, Leo Buckley, et al.
Thrombosis and Haemostasis|August 31, 2019
Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance ProgramJohn Fanikos, Debra Murwin, Fredrik Gruenenfelder, et al.
Arthritis and Rheumatism|December 13, 2005
Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical centerSandeep K Agarwal, Agnes L Maier, Lori B Chibnik, et al.
Joint Commission Journal on Quality and Patient Safety|March 30, 2006
How many hospital pharmacy medication dispensing errors go undetected?Jennifer L Cina, Tejal K Gandhi, William Churchill, et al.
Thrombosis and Haemostasis|September 16, 2021
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO TrialBehnood Bikdeli, Heather Hogan, Ruth B Morrison, et al.
Journal of Pharmacy Practice|July 20, 2024
Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa InhibitorsToni Fera, Allison Burnett, Jessica Grandoni, et al.
Journal of the American College of Cardiology|October 30, 2020
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19Gregory Piazza, Umberto Campia, Shelley Hurwitz, et al.
Journal of the American Medical Informatics Association : JAMIA|March 23, 2016
The frequency of inappropriate nonformulary medication alert overrides in the inpatient settingQoua L Her, Mary G Amato, Diane L Seger, et al.
Pageof 15